Cancer vaccine firm Oxford Vacmedix closes $12.5m Series A funding
South Korean and Chinese investors join round into Oxford University spinout developing cancer vaccines. Oxford Vacmedix UK Limited (OVM), a UK-based biopharma company focused on the development of cancer vaccines, has completed its Series A financing round of $12.5m (£9m) with a consortium of...
Days by the sea – a weekend of chocolate and radiotherapy
Blog posted by: Martin Christlieb Starting a conversation with strangers can be difficult at the best of times.  Starting a conversation on the subject of cancer and radiotherapy is even more so.  Engaging people on such subjects means catching their imagination, and fast. Setting a puzzle is an...
Medical Research Council grant success for Peter McHugh
Associate Professor Peter McHugh of the Department of Oncology has been awarded a 4 year grant from the Medical Research Council. The news comes hot on the heels of Professor McHugh's Cancer Research UK programme award. Grant success is tough, so this is a truly impressive achievement. The MRC...
Peter McHugh awarded CRUK grant to investigate how cancer cells resist treatment
The 5-year programme award will support research on the DNA repair mechanisms that protect cancer cells from therapy, informing the development of future therapies. Cancer therapies such as chemotherapy and radiotherapy aim to kill cancer cells by causing damage to their DNA. However, cancer cells...
Cancer en francais?
Blog posted by: Martin Christlieb On 25 January, I met a group of people whose lives have been touched by cancer.  Patients and their relatives whose world had been turned upside down by a disease that will affect nearly half of us. Cancer is terrible.  It threatens our lives and the resulting...
Successful CRUK research bursary for Oncology Clinical Fellow
Many congratulations to Robert Watson, a NIHR Academic Clinical Fellow in the laboratory of Benjamin Fairfax in the Department of Oncology. Robert was successful in his application for a CRUK pre-doctoral research bursary. Pre-doctoral research bursaries are awarded biannually by Cancer Research...
European Research Council success for Francesca Buffa
Congratulations to Associate Professor Francesca Buffa who has been awarded a five-year €2M grant by the European Research Council (ERC) to develop computer simulations of cancer cell behaviour, to help us personalise cancer treatment and prevent drug resistance. In many cases we know which parts...
Cancer communications and causing traffic jams
Blog posted by: Martin Christlieb Francesca Buffa has been awarded a five-year grant by the European Research Council (ERC) to develop computer simulations to personalise cancer treatment and prevent drug resistance. We increasingly understand which parts of a cell have gone wrong and make it...
Royal College of Radiologists accolade for Eric O'Neill
Congratulations to Professor Eric O'Neill who has been awarded honorary membership of the Royal College of Radiologists (RCR). The award is given in recognition of outstanding contributions to radiation biology, in particular teaching and training. Eric has been instrumental in a major piece of...
Regional Breast Cancer Academic Day marks NHS retirement for Professor Adrian Harris
This month the MRC Weatherall Institute of Molecular Medicine (WIMM) hosted the annual Regional Breast Cancer Academic Day, an event that brings together breast cancer teams from across the Thames Valley region. This year’s symposium involved the participation of over 70 attendees, including nurses...
A long and fateful journey
Blog posted by: Martin Christlieb What could be worse than cancer? Cancer that has spread. The average survival across all cancer types is about 50%. Most of the failures will occur in people whose tumours have spread (metastasised). How does a tumour spread? If we knew the answer to that we would...
Curiosity led to the Carnival
On Friday, 29 September the CRUK/MRC Oxford Institute for Radiation Oncology was to be found in the University of Oxford's Natural History Museum building a blood vessel along one of the cloisters overlooked by Charles Darwin.  The Oxford Institute’s blood vessel allowed visitors to explore the...
Wriggling worms and migrating cancer
Blog posted by: Martin Christlieb An article by Dr Mark Hill of the Oxford Institute for Radiation Oncology and Prof Aziz Aboobaker of the Department of Zoology has been selected as the cover article of the October Issue of Development.  The article describes a collaborative project to study the...
Oxford University scientist developing new treatments to tackle breast cancer that has spread to the brain
Professor Nicola Sibson of the Department of Oncology has been awarded a grant worth almost £200,000 by research charity Breast Cancer Now to fund cutting-edge research to uncover novel treatment combinations to control breast cancer that has spread to the brain. The news comes on Secondary Breast...
Worm study reveals role of stem cells in cancer
A new study carried out by the University of Oxford has used flat worms to look at the role of migrating stem cells in cancer. Researchers from the Aboobaker lab in the Department of Zoology used the worms (planarians) which are known for their ability to regenerate their tissues and organs...
Congratulations to our new Professor and Associate Professor
New anti-cancer drug
Congratulations to student prize winners
Oxford science goes to Durham
Pedals Power Cancer Research
Oxford Professor receives Honorary Degree from the Institute of Cancer Research
A UNIQ course - Oncology welcomes tomorrow's scientists
Oxford collaborative science opens the way for a new drug for bowel cancer patients across the UK
Medical Research Council - Festival of Medical Research.
Green Impact Team silver award
Researchers make breakthrough discovery in fight against colorectal cancer
FOXFIRE Combined Analysis
100km non-stop in 24 hours
Video makers visit the Department of Oncology
2016 Oxford Harrington Scholarship
Cancer Research UK Boat Race
New era in precision medicine for pancreatic cancer
Super Science
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.